dalteparin has been researched along with Cardiac Output, Low in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This was a randomized, standard treatment-controlled, 2-center pilot trial of 102 patients (52 receiving adjunctive therapy with enoxaparin at a dosage of 1." | 2.72 | Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial. ( Lekston, A; Nowak, J; Nowalany-Kozielska, E; Poloński, L; Szyguła-Jurkiewicz, B; Trzeciak, P; Wilczek, K; Wodniecki, J; Wojnicz, R; Zembala, M, 2006) |
| "Venous thromboembolism was previously regarded as a surgical problem, but occurs at least as frequently among medical patients." | 1.32 | Venous thromboembolic risk and prevention in acute medical illness. ( Hampton, KK, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hampton, KK | 1 |
| Wojnicz, R | 1 |
| Nowak, J | 1 |
| Szyguła-Jurkiewicz, B | 1 |
| Wilczek, K | 1 |
| Lekston, A | 1 |
| Trzeciak, P | 1 |
| Nowalany-Kozielska, E | 1 |
| Zembala, M | 1 |
| Wodniecki, J | 1 |
| Poloński, L | 1 |
1 trial available for dalteparin and Cardiac Output, Low
| Article | Year |
|---|---|
Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial.
Topics: Adult; Anticoagulants; Cardiac Output, Low; Cardiomyopathy, Dilated; Cardiovascular Agents; Chronic | 2006 |
1 other study available for dalteparin and Cardiac Output, Low
| Article | Year |
|---|---|
Venous thromboembolic risk and prevention in acute medical illness.
Topics: Acute Disease; Aged; Anticoagulants; Cardiac Output, Low; Enoxaparin; Female; Hospitalization; Human | 2003 |